These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

137 related items for PubMed ID: 15246161

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. In bcr-abl-positive myeloid cells resistant to conventional chemotherapeutic agents, expression of Par-4 increases sensitivity to imatinib (STI571) and histone deacetylase-inhibitors.
    Brieger A, Boehrer S, Schaaf S, Nowak D, Ruthardt M, Kim SZ, Atadja P, Hoelzer D, Mitrou PS, Weidmann E, Chow KU.
    Biochem Pharmacol; 2004 Jul 01; 68(1):85-93. PubMed ID: 15183120
    [Abstract] [Full Text] [Related]

  • 5. BCR-ABL activates pathways mediating cytokine independence and protection against apoptosis in murine hematopoietic cells in a dose-dependent manner.
    Cambier N, Chopra R, Strasser A, Metcalf D, Elefanty AG.
    Oncogene; 1998 Jan 22; 16(3):335-48. PubMed ID: 9467959
    [Abstract] [Full Text] [Related]

  • 6. Disruption of the inhibitor of apoptosis protein survivin sensitizes Bcr-abl-positive cells to STI571-induced apoptosis.
    Wang Z, Sampath J, Fukuda S, Pelus LM.
    Cancer Res; 2005 Sep 15; 65(18):8224-32. PubMed ID: 16166298
    [Abstract] [Full Text] [Related]

  • 7. Role of p21(WAF1/CIP1) as an attenuator of both proliferative and drug-induced apoptotic signals in BCR-ABL-transformed hematopoietic cells.
    Forster K, Obermeier A, Mitina O, Simon N, Warmuth M, Krause G, Hallek M.
    Ann Hematol; 2008 Mar 15; 87(3):183-93. PubMed ID: 17960378
    [Abstract] [Full Text] [Related]

  • 8. Bcr: a negative regulator of the Bcr-Abl oncoprotein.
    Wu Y, Ma G, Lu D, Lin F, Xu HJ, Liu J, Arlinghaus RB.
    Oncogene; 1999 Aug 05; 18(31):4416-24. PubMed ID: 10442632
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Induction of apoptosis by arachidonic acid in chronic myeloid leukemia cells.
    Rizzo MT, Regazzi E, Garau D, Akard L, Dugan M, Boswell HS, Rizzoli V, Carlo-Stella C.
    Cancer Res; 1999 Oct 01; 59(19):5047-53. PubMed ID: 10519422
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Sorafenib induces apoptosis specifically in cells expressing BCR/ABL by inhibiting its kinase activity to activate the intrinsic mitochondrial pathway.
    Kurosu T, Ohki M, Wu N, Kagechika H, Miura O.
    Cancer Res; 2009 May 01; 69(9):3927-36. PubMed ID: 19366808
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Role of SPA-1 in phenotypes of chronic myelogenous leukemia induced by BCR-ABL-expressing hematopoietic progenitors in a mouse model.
    Kometani K, Aoki M, Kawamata S, Shinozuka Y, Era T, Taniwaki M, Hattori M, Minato N.
    Cancer Res; 2006 Oct 15; 66(20):9967-76. PubMed ID: 17047059
    [Abstract] [Full Text] [Related]

  • 17. Cytogenetic characterization of a BCR-ABL transduced mouse cell line.
    Rudolph C, Hegazy AN, von Neuhoff N, Steinemann D, Schröck E, Stripecke R, Klein C, Schlegelberger B.
    Cancer Genet Cytogenet; 2005 Aug 15; 161(1):51-6. PubMed ID: 16080957
    [Abstract] [Full Text] [Related]

  • 18. Critical role for cyclin D2 in BCR/ABL-induced proliferation of hematopoietic cells.
    Jena N, Deng M, Sicinska E, Sicinski P, Daley GQ.
    Cancer Res; 2002 Jan 15; 62(2):535-41. PubMed ID: 11809706
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Ectopic expression of Par-4 leads to induction of apoptosis in CNS tumor cell lines.
    Vetterkind S, Boosen M, Scheidtmann KH, Preuss U.
    Int J Oncol; 2005 Jan 15; 26(1):159-67. PubMed ID: 15586236
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.